Although BCR::ABL1 inhibition led to a decrease in VDR mRNA expression, VDR mRNA levels were unchanged or mildly increased in the CML mouse model and Ba/F3 cells with ectopic expression of BCR::ABL1 and CML patients. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.